ZA881067B - Production of proteins in active forms - Google Patents

Production of proteins in active forms

Info

Publication number
ZA881067B
ZA881067B ZA881067A ZA881067A ZA881067B ZA 881067 B ZA881067 B ZA 881067B ZA 881067 A ZA881067 A ZA 881067A ZA 881067 A ZA881067 A ZA 881067A ZA 881067 B ZA881067 B ZA 881067B
Authority
ZA
South Africa
Prior art keywords
protein
proteins
production
rupturing
active forms
Prior art date
Application number
ZA881067A
Other languages
English (en)
Inventor
John Patroni Joseph
Original Assignee
Bunge (Australia) Pty. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bunge (Australia) Pty. Ltd. filed Critical Bunge (Australia) Pty. Ltd.
Publication of ZA881067B publication Critical patent/ZA881067B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA881067A 1987-02-20 1988-02-16 Production of proteins in active forms ZA881067B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI046287 1987-02-20

Publications (1)

Publication Number Publication Date
ZA881067B true ZA881067B (en) 1988-08-11

Family

ID=3772028

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881067A ZA881067B (en) 1987-02-20 1988-02-16 Production of proteins in active forms

Country Status (10)

Country Link
US (1) US4966963A (de)
EP (1) EP0279619B1 (de)
JP (1) JPS63264598A (de)
AT (1) ATE114319T1 (de)
AU (1) AU612133B2 (de)
CA (1) CA1326106C (de)
DE (1) DE3852140T2 (de)
ES (1) ES2065906T3 (de)
NZ (1) NZ223559A (de)
ZA (1) ZA881067B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU609824B2 (en) * 1987-06-15 1991-05-09 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
DE3887521T2 (de) * 1987-06-26 1994-08-18 Commw Scient Ind Res Org Durch virusneutralisierende und schützende monokonale antikörper erkanntes ibdv vp2 epitop.
US5136027A (en) * 1989-05-02 1992-08-04 Abbott Laboratories Method for renaturing proteins in the presence of alkyl sulfate detergents
US5101018A (en) * 1989-06-12 1992-03-31 International Minerals & Chemical Corp. Method for recovering recombinant proteins
EP0432419B1 (de) * 1989-12-05 1994-10-19 American Cyanamid Company Methode zur Auflösung und Naturation von Somatotropin unter Verwendung von einer niedrigen Harnstoffkonzentration
ES2119779T3 (es) * 1990-09-05 1998-10-16 Southern Cross Biotech Pty Ltd Solubilizacion de proteinas en formas activas.
US6566098B1 (en) * 1990-09-14 2003-05-20 The United States Of America As Represented By The Department Of Health And Human Services DNA encoding truncated hepatocyte growth factor variants
GB2281558B (en) * 1993-09-07 1997-02-19 Joseph Matthew Gaugas Supplying sulphur to plants
US5861372A (en) * 1996-02-22 1999-01-19 The Children's Medical Center Corporation Aggregate angiostatin and method of use
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US5840838A (en) * 1996-02-29 1998-11-24 University Of Kentucky Research Foundation Process for enhancing the activity of amyloid β peptides
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6566583B1 (en) 1997-06-04 2003-05-20 Daniel Facciotti Schizochytrium PKS genes
DK1588716T3 (da) 1998-08-06 2011-05-23 Mountain View Pharmaceuticals Peg-uratoxidase-konjugater og anvendelse deraf
US9534013B2 (en) * 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
CZ2007700A3 (cs) 2005-04-11 2008-02-27 Savient Pharmaceuticals, Inc. Variantní forma urátoxidázy a její použití
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
MX2007012547A (es) 2005-04-11 2008-03-11 Savient Pharmaceuticals Inc Formas variantes de urato oxidasa y uso de las mismas.
US20090081122A1 (en) * 2005-05-23 2009-03-26 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
EP2358909B1 (de) 2008-11-17 2015-09-02 Cornell University System zur protokollierung von wechselwirkungen zwischen proteinen im bakteriellen periplasma
CZ2011827A3 (cs) 2009-06-25 2012-09-26 Savient Pharmaceuticals, Inc. Zpusoby a sady pro predpovídání rizika reakce na infuzi a ztráty odezvy zpusobené protilátkami, monitorováním kyseliny mocové v séru behem lécby pegylovanou urikázou
WO2020160322A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
GR79124B (de) * 1982-12-22 1984-10-02 Genentech Inc
US4731440A (en) * 1985-02-22 1988-03-15 Monsanto Company Method of somatotropin solubilization using dimethylsulfone and naturation
ES8800957A1 (es) * 1985-02-22 1987-12-01 Monsanto Co Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina
US4766224A (en) * 1985-08-19 1988-08-23 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
AU1763188A (en) * 1987-06-15 1988-12-15 Bunge (Australia) Pty Ltd Recovery of proteins in active form

Also Published As

Publication number Publication date
EP0279619B1 (de) 1994-11-23
US4966963A (en) 1990-10-30
EP0279619A3 (en) 1990-04-11
AU1141288A (en) 1988-08-25
NZ223559A (en) 1989-09-27
JPS63264598A (ja) 1988-11-01
ES2065906T3 (es) 1995-03-01
CA1326106C (en) 1994-01-11
AU612133B2 (en) 1991-07-04
DE3852140T2 (de) 1995-04-06
ATE114319T1 (de) 1994-12-15
EP0279619A2 (de) 1988-08-24
DE3852140D1 (de) 1995-01-05

Similar Documents

Publication Publication Date Title
EP0279619A3 (en) Production of proteins in active forms
CS274681B2 (en) Method of erythropoietin's stabilized preparation production
DE3461886D1 (en) Process for preparing a whey product
CA2069450A1 (fr) Procede de fabrication d'un materiau pour osteoplastie a partir d'un tissu osseux naturel et materiau obtenu par ce procede
GR3006727T3 (de)
IL82209A0 (en) Insulin preparation
GR3003536T3 (de)
GR3006807T3 (de)
GB2190382B (en) "enhanced expression of human interleukin-2 or analogues in mammalian cells.
GR3007605T3 (de)
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
NZ235297A (en) Aqueous solution containing a protein and anionic polymer or salt and method of increasing the protein concentration of an aqueous solution
EP0273450A3 (en) Solubilizer for water-insoluble alginates, aqueous solution thereof and dissolvig method using the aqueous solution
EP0274219A3 (de) Interleukin-2 enthaltende Liposan-Zusammensetzung und Methode zu ihrer Herstellung
KR960006258B1 (en) Process for the preparation of n,n-disubstituted ñô-amino acids and their use in water-proofing leather and skins
ES2010247A6 (es) Dispositivo de desplazamiento de un conjunto de instrumentos de medicion ony de intervencion dentro de un pozo y su metodo de medicion yno de intervencion.
SU1593570A3 (ru) Cпocoб пoлучehия пpoизboдhыx 3,4-дигидpo-3-tиokco-2 h-1,4-бehзokcaзиh-4-уkcуchoй kиcлotы